The novel approach of this peptide represents a major development in the management of type 2 diabetes. Unlike existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide740818.blogdeazar.com/42382958/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment